Dry Ice Becomes a Must for COVID Vaccine Distribution

 

As the world eagerly awaits the manufacture and distribution of the COVID vaccine, many are considering the many steps that will be needed to deliver these vital vials of medication to the hospitals and pharmacies where they’ll be injected. Moderna’s vaccine has to be shipped at -4˚F, then can be stored at that temperature for six months; but once thawed, it must be refrigerated between 36˚F-46˚F, and must be used within 30 days. Pfizer’s vaccine, on the other hand, must be kept at an exceedingly frigid -94˚F, and once transferred to a refrigerator, must be administered within five days.

MarketScale Radio hosts Daniel Litwin and Tyler Kern look into a CNBC report discussing the challenges around keeping COVID vaccines at their optimum temperatures to ensure their efficacy, including limited hospital resources and budgets that won’t allow for industrial freezing units, the complexities of using and storing dry ice, and whether the vaccine will be a boost to struggling cold chain businesses, funneling some much needed liquid cash into the economy.

  • Pfizer and BioNTech’s COVID-19 vaccine needs to be stored at ultra-cold temperatures.
  • Hospitals, already operating on tight budgets, opt for dry ice in bulk over industrial freezers.
  • This has led to a boom in dry ice sales, showing the potential for vaccine distribution to boost unexpected sectors of the economy.

Follow us on social media for the latest updates in B2B!

Image

Latest

decarbonization efforts
Decarbonization Efforts and Goals in the Aerospace Industry
September 18, 2024

As the aerospace industry intensifies its focus on decarbonization efforts, the sector faces increasing pressure to reduce its carbon footprint in line with global climate goals. This conversation is particularly relevant as the industry contributes approximately 3.5% of global emissions. To stay competitive and comply with the Paris Agreement targets, aerospace companies are adopting…

Read More
Care Anywhere: The Journey Begins
Care Anywhere: The Journey Begins
September 18, 2024

In the inaugural episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims, CMO of CGFNS International, Inc., introduces the organization’s mission to address global healthcare workforce challenges. Joining the discussion are Dr. Peter Preziosi, President and CEO of CGFNS International, Inc., and Julia To Dutka, Chief of the CGFNS Global Health Workforce…

Read More
revolutionizing drug development
Revolutionizing Drug Development: The Patient Voice is Leading the Way!
September 18, 2024

Revolutionizing drug development is pivotal in today’s healthcare landscape, particularly as the patient voice grows louder and more influential in shaping therapies. The latest episode of Healthcare Rethink, a FinThrive podcast, looks at this transformative trend. In an engaging discussion, host Brian Urban welcomes Wendy Erler, the VP of Global Patient Experience at Alexion…

Read More
we matter
We All Deserve to Feel We Matter: Insights from Stephen “Shed” Shedletzky
September 17, 2024

In today’s fast-paced business environment, ensuring we matter at work is more important than ever. Research reveals that an employee’s relationship with their boss can impact their well-being more than their doctor or spouse, proving that leaders play a crucial role in shaping an environment where we matter. Stephen “Shed” Shedletzky, a Leadership Expert…

Read More